{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "133.75",
    "chg": 0.5,
    "chgp": "0.38%",
    "dir": 1,
    "prev_price": "133.25",
    "mcapval": "153.62 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "2.93 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-4000883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_mojoScore_4000883.png",
        "date": "2026-05-20 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-signal-renewed-price-attractiveness-4000015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_valuationdot_4000015.png",
        "date": "2026-05-20 08:00:32",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Hold, signals a potential reappraisal of the stock’s price attractiveness amid improving fundamentals and relative sector comparisons."
      }
    ],
    "total": 15,
    "sid": "286243",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Year Ended 30Th June 2026.",
      "datetime": "05-Aug-2026",
      "details": "Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and Year ended 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Aug-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakash Shah",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "03-Aug-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mihir Shah",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parnax Lab Ltd is Rated Hold

2026-05-20 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read More

Parnax Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-20 08:00:32

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Hold, signals a potential reappraisal of the stock’s price attractiveness amid improving fundamentals and relative sector comparisons.

Read More

View All News